Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients,... Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.885 | -8.99847483477 | 9.835 | 10.85 | 8.95 | 13772 | 9.93711094 | DR |
| 4 | 0.64 | 7.70156438026 | 8.31 | 10.85 | 8.09 | 9544 | 9.54525048 | DR |
| 12 | -0.6 | -6.28272251309 | 9.55 | 12.54 | 8.09 | 10155 | 9.89510518 | DR |
| 26 | 1.315 | 17.223313687 | 7.635 | 12.54 | 7.41 | 7085 | 9.75671375 | DR |
| 52 | 1.668 | 22.9057951112 | 7.282 | 12.54 | 5.97 | 6792 | 9.0191805 | DR |
| 156 | -0.3 | -3.24324324324 | 9.25 | 12.54 | 5.5 | 4431 | 8.64448846 | DR |
| 260 | -0.5 | -5.29100529101 | 9.45 | 12.54 | 5.5 | 4342 | 8.64534685 | DR |
Implanting
5分前
Crypttolit
6分前
gemstone57
6分前
Crypttolit
7分前
JP313
7分前
Runners123
7分前
Mr Smith 34
8分前
Runners123
10分前
norisknorewards
10分前
Wizzerd
11分前
mars2063
12分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。